(Q42167241)

English

Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations

scientific article published on May 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

Robert A Hauser

3

object named as

Robert A Hauser

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

author name string

Bonnie P Hersh

1

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Nancy L Earl

2

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Mark Stacy

4

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

language of work or name

0 references

publication date

1 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

927-931

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23040

21 January 2018

Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23040

21 January 2018

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23040

21 January 2018

Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23040

21 January 2018

Identifiers

10.1002/MDS.23040

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42167241&oldid=1935100310"